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Abstract
The objective of this study was to determine if the inverse relationship between perceived physical 
fitness (pFIT) and exercise frequency (ExFreq) levels and chronic inflamma-tion and oxidative 
stress exists after making statistical adjustments for confounders including body mass index 
(BMI), age, gender, and cigarette smoking. Study partici-pants (60% female and 40% male; n = 
998) varied widely in age (18–85 years) and BMI (16.7–52.7 kg/m2) completed an extensive 
medical/health and lifestyle questionnaire, and data were used to establish pFIT and ExFreq 
tertiles. Biomarkers included serum C-reactive protein (CRP), total blood leukocytes, five plasma 
cytokines [interleukin (IL)-6, IL-10, tumor necrosis factor-a (TNF-a), monocyte chemoattractant 
protein-1 (MCP1), and granulocyte colony-stimulating factor (GCSF)], F2-isoprostanes, ferric 
reducing ability of plasma (FRAP), and oxygen radical absorbance capacity (ORAC). A general 
linear model was used to examine relationships between pFIT and ExFreq with inflammation and 
oxidative stress while controlling for age, gender, BMI, and smoking. Benjamini–Hochberg 
method for false discovery rate correction was used for multiple testing corrections. Significant 
tests (P < 0.05) for trend were found for the effect of pFIT and ExFreq on CRP, white blood cell, 
IL-6, TNF-a, GCSF, and F2-isoprostanes, but not MCP1, IL-10, FRAP, and ORAC, after 
adjustment for confounders. These data indicate that an inverse relationship exists among 
chronic inflam-mation, oxidative stress, and pFIT and ExFreq at the community level even after 
adjustment for important confounders.
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The objective of this study was to determine if the inverse 
relationship between perceived physical fitness (pFIT) and 
exercise frequency (ExFreq) levels and chronic inflamma- 
tion and oxidative stress exists after making statistical 
adjustments for confounders including body mass index 
(BMI), age, gender, and cigarette smoking. Study partici- 
pants (60% female and 40% male; n = 998) varied widely 
in age (18–85 years) and BMI (16.7–52.7 kg/m2) completed 
an extensive medical/health and lifestyle questionnaire, 
and data were used to establish pFIT and ExFreq tertiles. 
Biomarkers included serum C-reactive protein (CRP), 
total blood leukocytes, five plasma cytokines [interleukin 
(IL)-6, IL-10, tumor necrosis factor-a (TNF-a), monocyte 
chemoattractant protein-1 (MCP1), and granulocyte 
colony-stimulating factor (GCSF)], F2-isoprostanes, ferric 
reducing ability of plasma (FRAP), and oxygen radical 
absorbance capacity (ORAC). A general linear model was 
used to examine relationships between pFIT and ExFreq 
with inflammation and oxidative stress while controlling 
for age, gender, BMI, and smoking. Benjamini–Hochberg 
method for false discovery rate correction was used for 
multiple testing corrections. Significant tests (P < 0.05) 
for trend were found for the effect of pFIT and ExFreq 
on CRP, white blood cell, IL-6, TNF-a, GCSF, and F2-
isoprostanes, but not MCP1, IL-10, FRAP, and ORAC, 
after adjustment for confounders. These data indicate 
that an inverse relationship exists among chronic inflam- 
mation, oxidative stress, and pFIT and ExFreq at the 
community level even after adjustment for important 
confounders. 
Physical inactivity has been linked to numerous chronic 
diseases or chronic disease risk factors (Booth et al., 
2000). Atherosclerosis, type 2 diabetes, metabolic syn- 
drome, chronic obstructive pulmonary disease, arthritis, 
and osteoporosis are associated with chronic low-grade 
inflammation and oxidative stress (Morrow, 2005; Basu, 
2008; Beavers et al., 2010). Physical activity has poten- 
tial benefits on systemic inflammation and oxidative 
stress biomarkers frequently employed to study the like- 
lihood of developing these disease states. The acute 
phase protein C-reactive protein (CRP) is the most fre- 
quently measured inflammation  biomarker in physical 
activity-related studies, with others also analyzing total 
blood leukocytes [white blood cell (WBC)], cytokines 
interleukin (IL)-6, and tumor necrosis factor-a (TNF-a; 
Beavers et al., 2010). Few data are available on the 
relationship between physical activity and other 
inflammation-related cytokines such as granulocyte 
colony-stimulating factor (GCSF), monocyte chemoat- 
tractant  protein-1  (MCP1),  and  the  anti-inflammatory 
cytokine IL-10 (Suzuki et al., 2002). The linkage 
between physical activity and F2-isoprostanes, a widely 
used and highly regarded biomarker of oxidative stress, 
is also not well established (Morrow, 2005; Vincent & 
Taylor, 2006; Fisher-Wellman et al., 2009). 
Systemic inflammation and oxidative stress are at 
lower levels in groups with higher fruit and vegetable 
intake and lower body mass index (BMI; Esmaillzadeh 
et al., 2006; Vincent & Taylor, 2006; Selvin et al., 2007; 
Holt et al., 2009). The association of physical activity to 
inflammation and oxidative stress is equivocal (Vincent 
& Taylor, 2006; Fisher-Wellman  et al., 2009; Beavers 
et al., 2010). Most randomized-controlled exercise- 
intervention studies have yet to demonstrate that 
inflammation and oxidative stress are decreased in the 
absence of weight loss despite increases in exercise 
capacity (Kelley & Kelley, 2006; Stewart et al., 2007; 
2010; Arsenault et al., 2009; Beavers et al., 2010; 
Church et al., 2010; Thompson et al., 2010). Conversely, 
other   well-controlled   exercise   training   studies   have 
reported decreases in inflammation in both diseased 
(Kadoglou et al., 2007) and healthy (Kohut et al., 2006) 
subjects independent of weight change. Cross-sectional 
studies consistently show inverse relationships between 
biomarkers of systemic inflammation and physical 
activity or fitness (Abramson & Vaccarino, 2002; Ford, 
2002; King et al.,  2003;  Colbert  et al.,  2004;  Elosua 
et al., 2005; Pitsavos et al., 2005), with little information 
available regarding oxidative stress. 
Available cross-sectional studies have not measured 
the relationship of perceived physical fitness (pFIT) 
and/or leisure-time exercise frequency (ExFreq) levels 
on both inflammation and oxidative stress using a variety 
of outcome measures in groups ranging widely in age 
and BMI. The purpose of this study was to determine if 
inflammation and oxidative stress are inversely related to 
physical activity and fitness in a heterogeneous group of 
subjects after adjustment for potential confounders. 
Methods 
Subjects 
Study participants (n = 998; 60.4% female and 39.6% male; 18–85 
years of age; BMI of 16.7–52.7 kg/m2) were recruited via mass 
advertising from the community. Subjects had to be noninstitu- 
tionalized, and women were excluded if pregnant or lactating. No 
other exclusion criteria were employed, and both diseased and 
non-diseased subjects were admitted into the study, with monitor- 
ing of disease status and medication use. Reports have been pub- 
lished from this study, with a focus on quercetin supplementation, 
inflammation, and oxidative stress (Heinz et al., 2010; Shanely 
et al., 2010). Quercetin supplementation at two doses (500 mg/day 
and 1000 mg/day) had no influence on immune function, upper 
respiratory tract infection, oxidative stress or plasma antioxidant 
capacity (Heinz et al., 2010; Shanely et al., 2010), and the data 
from the same subjects were reanalyzed to investigate the influ- 
ence of pFIT and ExFreq on biomarkers of inflammation, oxida- 
tive stress, and plasma antioxidant capacity after adjustment for 
important confounders. There was no statistical difference in the 
distribution of supplement subjects among the pFIT or ExFreq 
tertiles (P = 0.44, chi-square test). Written informed consent was 
obtained from each subject, and the Appalachian State University 
institutional review board approved all experimental procedures. 
Study design 
Two weeks prior to the start of the study, subjects provided demo- 
graphic and lifestyle habit information using a survey posted on 
the website http://surveymonkey.com (Portland, Oregon, USA). 
Subjects without Internet access were mailed with a printed 
version of the questionnaire, with instructions to complete all 
questions prior to their first lab session. Subjects reported to the 
lab at the beginning and end of the 12-week period, with height 
and body mass measured with a stadiometer and an electric scale 
(Tanita, Arlington Heights, Illinois, USA), respectively. Pre- and 
post-study height and body mass data were averaged, with BMI 
calculated as kg/m2. 
pFIT levels were reported in response to the question, “In 
general, compared to other persons your age, rate how physically 
fit you are.” Subjects responded using a 10-point Likert scale, with 
1 denoting “not at all physically fit,” 5 denoting “somewhat physi- 
cally fit,” and 10 denoting “extremely physically fit,” similar to 
Gerber et al. (2010). Responses by subjects to this question cor- 
relate well with measures of objective physical fitness, perceived 
well-being, and sleep habits (Plante et al., 1998). Subjects were 
grouped into pFIT tertiles, with 1–5 corresponding to low fitness, 
6–7 corresponding to medium fitness, and 8–10 corresponding to 
high fitness. 
Leisure-time ExFreq habits were assessed through answers to 
this categorical question taken from the National Health Interview 
Survey [National Center for Health Statistics (U.S.), 1999]: 
“Outside of your normal work or daily responsibilities, how often 
do you engage in exercise that at least moderately increases your 
breathing and heart rate, and makes you sweat, for at least 20 min 
[such as brisk walking, cycling, swimming, jogging, aerobic dance, 
stair climbing, rowing, basketball, racquetball, vigorous yard work 
(gardening), etc.].” Response categories included seldom or never, 
less than 1, 1–2, 3–4, or 5 or more times per week. Subjects were 
grouped into leisure-time aerobic ExFreq tertiles of <1, 1–4, or 2::5 
times per week. Milton et al. (2011) demonstrate that single-item 
physical activity questions objectively measure activity levels 
when compared with other instruments. 
Outcome measures 
Each subject provided two overnight-fasted blood samples 
(between 7 a.m. and 9 a.m.) separated by 12 weeks; plasma biomar- 
kers were averaged from the two blood samples. Blood samples 
were centrifuged in sodium heparin or ethylenediaminetetraacetic 
acid tubes, and plasma was aliquoted, immediately flash-frozen in 
liquid nitrogen, and then stored at -80°C until analysis. 
Serum CRP (high sensitivity) was measured in a clinical labo- 
ratory using an LX-20 clinical analyzer (Beckman, Brea, Califor- 
nia, USA) (Nieman et al., 2007) and has an intra-assay coefficent 
of variation (CV) of 5%. Enzyme-linked immunosorbent assays 
were used to measure total plasma concentrations of IL-6 (high 
sensitivity), GCSF (high sensitivity), MCP1, TNF-a, and IL-10 
(high sensitivity) in accordance with the manufacturer’s protocols 
(R&D Systems, Inc., Minneapolis, Minnesota,  USA).  Each 
subject sample and the standards provided by the manufacturer 
were analyzed in duplicate (Nieman et al., 2005; Nieman et al., 
2007). Within-subject samples were analyzed on the same assay 
plate to decrease inter-kit assay variability, and the intra-assay CV 
for all variables was less than 10%. The minimum detectable 
concentration of  IL-6 (high sensitivity) was 0.039 pg/mL, 
GCSF (high sensitivity) 0.8 pg/mL, MCP1 5.0 pg/mL, TNF- 
a 0.106 pg/mL, and IL-10 (high sensitivity) 0.2 pg/mL. Data 
were analyzed with SOFTmax software (Molecular Devices, Sun- 
nyvale, California, USA). A complete blood count with leukocyte 
differential was analyzed in the Watauga Medical Center Clinical 
Hematology Laboratory (Boone, North California, USA), and the 
WBC count has a CV of 2%. 
Plasma F2-isoprostanes, a measure of oxidative stress, were 
determined as previously described (Shanely et al., 2010). Plasma 
samples were used to extract free F2-isoprostanes with deuterated 
[2H4] prostaglandin F2a added as an internal standard. The mixture 
was then added to a C18 Sep Pak column (Waters Corporation, 
Milford, Massachusetts, USA), followed by silica solid-phase 
extractions. F2-isoprostanes were converted to pentafluorobenzyl 
esters, subjected to thin-layer chromatography, and converted to 
trimethylsilyl ether derivatives. Samples were analyzed by a nega- 
tive ion chemical ionization gas chromatography-mass spectros- 
copy (GC-MS) using an Agilent 6890N gas chromatography 
interfaced to an Agilent 5975B inert MSD mass spectrometer 
(Agilent Technologies, Inc., Santa Clara, California, USA). The 
F2-isoprostanes assay has detection limit of ~5 pg, and the CV is 
10%. Plasma antioxidant capacity was determined by two inde- 
pendent measures; the ferric reducing ability of plasma (FRAP) 
assay and the oxygen radical absorbance capacity (ORAC). The 
detection limits and CVs of the FRAP and ORAC assays are 100–
1000 mmol/L and 6.25–100 mmol/L and 10% and 5%, 
respectively (Shanely et al., 2010). 
 
 
 
Table 1. Tertiles of subject perceived physical fitness and leisure-time exercise frequency 
 
 
Variable Tertiles from low to high   c2 F probability P-value 
Low Medium High 
Male Female Male Female Male Female 
 
 
pFIT n = 93 n = 246 n = 134 n = 176 n = 166 n = 183 0.001 
Age 46.1 ± 15.2 44.6 ± 14.0 43.7 ± 16.1 46.6 ± 15.9 45.2 ± 19.0 49.4 ± 17.1* 0.550 0.007 
BMI 30.7 ± 5.9 29.3 ± 6.7 27.7 ± 4.8*  25.3 ± 4.4*  25.5 ± 3.4*  23.35 ± 4.0* 0.001 0.001 
Smoking habit (all) 11.7% 5.9% 4.0% 0.001 
ExFreq n = 65 n = 149 n = 235 n = 337 n = 93 n = 119 0.008 
Age 47.8 ± 15.2 45.7 ± 14.4 45.1 ± 17.4 46.1 ± 15.9 42.4 ± 17.6 49.3 ± 16.2 0.143 0.120 
BMI 29.3 ± 5.2 28.8 ± 6.9 27.3 ± 4.9 26.2 ± 5.5* 26.5 ± 4.8* 23.9 ± 4.4* 0.002 0.001 
Smoking habit (all) 12.1% 7.6% 1.4% 0.001 
 
 
Perceived physical fitness level (pFIT), low (1–5 on a Likert scale), medium (6–7), and high (8–10). Leisure-time exercise frequency (ExFreq, days/week), 
low (1 day/week), medium (1–4), high (2::5). Data are reported as mean ± standard deviation. 
*P 0.05 compared with the low tertile. 
BMI, body mass index. 
 
 
Table 2. Tertiles of perceived physical fitness from low to high 
 
 
Variable Perceived physical fitness P for trend Factors selected 
 
 Low Medium High  
TNF-a (pg/mL) 1.95 (1.77–2.15) 1.91 (1.72–2.12) 1.66 (1.50–1.83)*† 0.003 Age, pFIT, sex, smoking 
MCP1 (pg/mL) 169 (163–175) 169 (163–176) 171 (165–177) 0.693 Age, sex, smoking, pFIT 
GCSF (pg/mL) 33.7 (31.9–35.5) 32.2 (30.4–34.1) 30.1 (28.4–31.9)*† 0.001 Sex, BMI, pFIT, smoking 
IL-10 (pg/mL) 1.65 (1.47–1.86) 1.49 (1.31–1.69) 1.43 (1.24–1.64) 0.076 Sex, BMI, pFIT, smoking 
WBC (109/L) 6.61 (6.43–6.79) 6.35 (6.15–6.55)* 6.10 (5.90–6.31)*† 0.001 BMI, amoking, pFIT, age 
FRAP (mmol/L) 592 (577–606) 581 (566–596) 585 (571–600) 0.619 Sex, age, BMI, pFIT 
Perceived physical fitness (pFIT) level, low (1–5 on a Likert scale), medium (6–7), and high (8–10). Data for all but WBC and FRAP are presented as 
antilogs of least squares means after model adjustment (± 95% confidence intervals). P-values for trend were adjusted for multiple tests by using false 
discovery rate. 
*Significantly different from low fitness; †significantly different from medium fitness. Factors selected by the model are reported in rank order of 
importance. 
TNF-a, tumor necrosis factor-a; MCP1, monocyte chemotactic protein-1; GCSF, granulocyte colony-stimulating factor; IL-10, interleukin-10; WBC, white 
blood cell count; FRAP, ferric reducing ability of plasma (expressed as ascorbic acid equivalents). 
 
 
Statistics 
Subject characteristics were contrasted between tertiles within 
gender using one-way analysis of variance for age and BMI, and 
the categorical variables, gender and smoking, were analyzed 
using chi-square analysis (Table 1). The general linear model 
(GLM) was used to  examine  the  effect  of  perceived  fitness 
(or ExFreq) on each plasma biomarker. The GLMSELECT pro- 
cedure in SAS (version 9.1.3; SAS Institute, Inc., Cary, North 
Carolina, USA) was used to identify confounding variables. The 
candidate confounders that the GLMSELECT procedure selected 
from were age, gender, BMI, and smoking habit. Disease  was 
added as a potential confounder to the model of each biomarker; 
however, the analyses suggest that disease does not affect the 
relationship between each biomarker and pFIT or ExFreq.  For 
each marker, the model with the smallest Akaike’s information 
corrected criterion was selected, and then a trend test was per- 
formed to study the effect of pFIT (or ExFreq) on the biomarker 
marker after adjusting for confounders. Benjamini–Hochberg 
method for false discovery rate correction in the MULTTEST 
procedure in SAS was used for multiple testing correction. 
Pairwise comparison  was performed  among the  three pFIT (or 
ExFreq) levels. The normality of the residuals from each model 
was examined. When the normality assumption was violated, out- 
liers with studentized residue 2.5 or -2.5 were excluded, and 
when needed, natural log transformation on the response variable 
was performed. In Tables 2 and 3, P for trend values represent 
adjusted pFIT and ExFreq data for the outcome measures, and in 
Figs 1, 2, and 3, P-values are listed separately for factors selected 
by the model. 
 
Results 
Table 1 summarizes age, BMI, and smoking habit data 
for males and females across tertiles from low to high 
pFIT levels and leisure-time ExFreq. BMI and smoking 
habit differed significantly across pFIT and ExFreq ter- 
tiles for both genders. Ages were similar across pFIT and 
ExFreq tertiles except for pFIT in females. 
Across pFIT tertiles, CRP (Fig. 1a), IL-6 (Fig. 2a), 
TNF-a, GCSF, and WBC, but not MCP1 or IL-10 
(Table 2) inflammation biomarkers, differed signifi- 
cantly after adjustment for factors selected by the model. 
 
 
 
Table 3. Tertiles of leisure-time exercise frequency from low to high 
 
 
Variable Leisure-time exercise frequency P for trend Factors selected 
 
 Low Medium High  
TNF-a (pg/mL) 2.01 (1.80–2.24) 1.80 (1.64–1.96)* 1.86 (1.65–2.10) 0.305 Age, smoking, sex, BMI, ExFreq 
MCP1 (pg/mL) 169 (163–176) 169 (164–174) 176 (168–183)† 0.133 Age, sex, smoking, ExFreq 
GCSF (pg/mL) 33.9 (31.9–36.1) 32.1 (30.6–34.7) 29.1 (27.2–31.1)*† 0.001 Sex, BMI, ExFreq, smoking 
IL-10 (pg/mL) 1.62 (1.44–1.82) 1.51 (1.40–1.62) 1.60 (1.41–1.80) 0.850 BMI, sex, ExFreq 
WBC (109/L) 6.58 (6.37–6.80) 6.38 (6.21–6.55)* 6.12 (5.89–6.35)*† 0.001 BMI, smoking, ExFreq, age 
FRAP (mmol/L) 577 (560–596) 584 (573–595) 604 (587–623)*† 0.047 Sex, age, BMI, ExFreq 
Leisure-time exercise frequency (ExFreq, days/week), low (1 day/week), medium (1–4), and high (2::5). Data for all but WBC and FRAP are presented as 
antilogs of least squares means after model adjustment (± 95% confidence intervals). P-values for trend were adjusted for multiple tests using false 
discovery rate. 
*Significantly different from low ExFreq; †significantly different from medium ExFreq. Factors selected by the model are reported in rank order of 
importance. 
TNF-a, tumor necrosis factor-a; MCP1, monocyte chemotactic protein-1; GCSF, granulocyte colony-stimulating factor; IL-10, interleukin-10; WBC, white 
blood cell count; FRAP, ferric reducing ability of plasma (expressed as ascorbic acid equivalents). 
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Fig. 1. Plasma C-reactive protein (CRP) for each of the factors selected into (a) the perceived physical fitness level (pFIT) and (b) the 
leisure-time exercise frequency (ExFreq) model. Data are antilogs of least squares means after model adjustment (± 95% confidence 
intervals). Factors selected are plotted in rank order of importance with the P for trend value reported for each factor. 
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Fig. 2. Plasma interleukin (IL)-6 for each of the factors selected into (a) the perceived physical fitness level (pFIT) and (b) the 
leisure-time exercise frequency (ExFreq) model. Data are antilogs of least squares means after model adjustment (± 95% confidence 
intervals). Factors selected are plotted in rank order of importance with the P for trend value reported for each factor. 
 
 
Across  ExFreq  tertiles,  CRP (Fig. 1b),  IL-6  (Fig. 2b), 
GCSF,  and  WBC,  but  not  TNF-a,  MCP1,  or  IL-10 
(Table 3)   inflammation   biomarkers,   differed   signifi- 
cantly after adjustment for factors selected by the model. 
Across  pFIT  tertiles,  F2-isoprostanes  (Fig. 3a)  but 
not   FRAP  (Table 2),   oxidative   stress   and   capacity 
biomarkers,   respectively,   differed   significantly   after 
adjustment  for  factors  selected  by  the  model. Across 
ExFreq  tertiles,  F2-isoprostanes  (Fig. 3b)  and  FRAP 
(Table 3)   differed   significantly   after   adjustment   for 
factors selected by the model. None of the factors in the 
model (pFIT, ExFreq, age, sex, or smoking) were found 
to have a significant relationship with ORAC (see online 
Supporting  Information). 
For both pFIT and ExFreq tertiles, BMI was the factor 
selected first by the model for CRP, IL-6, WBC, and 
F2-isoprostanes,  with  sex  selected  first  for  GCSF  and 
FRAP, and age selected first for TNF-a and MCP1 
(Tables 2 and 3, Figs 1–3, see online Supporting Infor- 
mation). In general, the effect of the factors pFIT or 
ExFreq ranked second or third when compared with the 
other factors in the model. 
 
Discussion 
This community-based epidemiologic study was unique 
in that the relationship of both pFIT levels and leisure- 
time ExFreq on 10 measures of inflammation and oxi- 
dative stress was investigated in approximately 1000 
male and female adults between the ages of 18 and 85 
years. The primary finding of this study was that CRP, 
WBCs, IL-6, TNF-a, GCSF, and F2-isoprostanes were 
significantly lower when comparing high-to-low tertiles 
for both pFIT and ExFreq, after adjustment for multiple 
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Fig. 3. Plasma F2-isoprostane for each of the factors selected into (a) the perceived physical fitness level (pFIT) and (b) the leisure-time 
exercise frequency (ExFreq) model. Data are antilogs of least squares means after model adjustment (± 95% confidence intervals). 
Factors selected are plotted in rank order of importance with the P for trend value reported for each factor. 
 
 
confounders. These data indicate that in a large, hetero- 
geneous sample of community-dwelling adults, an 
inverse relationship exists between multiple inflamma- 
tion and oxidative stress biomarkers and pFIT and 
ExFreq even after adjustment for potential confounders. 
Overall, the effect of pFIT and ExFreq on CRP was 
strong, but for all other biomarkers, the effect was 
modest and generally ranked behind BMI or demo- 
graphic factors in rank order of importance. 
CRP is a well-characterized biomarker of chronic 
inflammation. CRP was significantly influenced by BMI, 
gender, age, and smoking status, but after adjustment for 
these factors, subjects in the upper tertiles for pFIT and 
ExFreq had 40–46% lower CRP levels than those in the 
lower tertiles. Our data are in agreement with three other 
studies that have examined the influence of pFIT (Ford,  
2002;  Pitsavos  et al.,  2005)  and  ExFreq  (King  et al., 
2003) on CRP levels in heterogeneous populations. An 
elevated WBC is indicative of inflammation and is asso- 
ciated with adverse cardiovascular events (Danesh et al.,  
1998). WBCs were 7.0–7.7% lower in subjects in the 
upper vs lower tertiles for pFIT and ExFreq in agreement 
with comparable studies (Ford, 2002; King et al., 2003; 
Pitsavos et al., 2005). 
Our study also determined if pFIT and ExFreq were 
related to five plasma cytokines (IL-6, TNF-a, GCSF, 
MCP1, and IL-10). IL-6 was significantly lower in the 
high vs low pFIT (19%) and ExFreq (18%) tertiles. Like- 
wise, TNF-a was significantly lower in the high vs low 
pFIT (-15%) and ExFreq (-8%) tertiles. The magnitude 
of the inverse  relationship between pFIT and  IL-6 or 
TNF-a has been reported in studies with similar subject 
characteristics (Pitsavos et al., 2005; Arsenault et al.,  
2009), but this is the first such report for ExFreq. 
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The cytokine GCSF is primarily secreted by mono- 
cytes and macrophages; however, other immune and 
nonimmune cell types can also secrete GCSF (Barreda 
et al., 2004). Neutrophil proliferation, differentiation, 
survival, and activation are regulated by GCSF 
(Barreda et al., 2004). Additionally, GCSF decreases 
pro-inflammatory cytokine secretion by activated 
monocytes and macrophages (Barreda et al., 2004). 
Plasma levels of GCSF increase in response to intense 
long- and short-duration exercise (Yamada et al., 2002;  
Pitsavos et al., 2005; Nieman et al., 2007). However, to 
our knowledge,  this is  the first study  to determine  if 
there is a link between pFIT or ExFreq and circulating 
GCSF levels. We found an inverse relationship between 
plasma GCSF levels and pFIT or ExFreq; plasma 
GCSF levels were significantly lower in the high pFIT 
(-10.5%) and ExFreq (-14.2%) tertiles. GCSF may 
support the anti-inflammatory actions of IL-6 by induc- 
ing its release and inhibiting the release of IL-1b and 
TNF-a (Suzuki et al., 2002; Nieman  et al.,  2005).  In 
the community setting, the lower levels of GCSF reflect 
the lower degree of inflammation in the high pFIT and 
ExFreq tertiles. 
MCP1  is  a  pro-inflammatory   cytokine   produced 
by macrophages and adipocytes and other cell types 
(Gustafson, 2010). MCP1 facilitates the infiltration 
and activation of monocytes, macrophages, and lym- 
phocytes, and induces IL-6 and TNF-a secretion from 
adipocytes and macrophages, respectively (Gustafson, 
2010). Like many other inflammatory cytokines, plasma 
MCP1 increases acutely in response to vigorous exercise 
(Nieman et al., 2005, 2007). Recent evidence suggests 
that short-term weight loss, but not  exercise  alone, 
can decrease plasma MCP1 levels in obese subjects 
(Christiansen et al., 2010). Our data  indicate  that 
plasma MCP1 is related to age, gender, and smoking 
but not pFIT, ExFreq, or BMI (see online Supporting 
Information). 
IL-10,  an  exercise  responsive   (Nieman   et al., 
2005, 2007; Kadoglou et al., 2007) anti-inflammatory 
cytokine, inhibits synthesis of IL-12, thus inhibiting 
interferon-g production. We found that plasma IL-10 is 
more related to gender and BMI than to pFIT of ExFreq 
(see online Supporting Information). Our data from a 
heterogeneous age-group extend the previous report of 
a lack of an apparent relationship between IL-10 and 
exercise habit in  a  cohort  of  elderly  subjects  (Elosua 
et al., 2005). 
Obesity, old age, and chronic disease are associated 
with oxidative stress (Morrow, 2005; Voss & Siems,  
2006; Basu, 2008). Regular exercise can decrease lipid 
peroxidation, a measure of oxidative stress, in patients 
with cardiovascular and metabolic diseases (Fisher- 
Wellman et al., 2009). We assessed oxidative stress with 
F2-isoprostanes, a sensitive and stable marker of lipid 
peroxidation (Morrow, 2005). Our data indicate that oxi- 
dative stress is significantly lower in high pFIT (-7.1%) 
and high ExFreq (-7.1%) tertiles. Plasma F2-isoprostanes 
have been correlated with BMI (Urakawa et al., 2003), 
but in our study, the effect of pFIT and ExFreq remained 
significant after adjusting for BMI. Exercise intervention 
studies have demonstrated that the training period must be 
of sufficient duration (e.g. greater than 8 weeks), and it 
must induce a substantial improvement in fitness to sig- 
nificantly decrease F2-isoprostanes (Schmitz et al., 2008; 
Campbell et al., 2010). To our knowledge, this is the first 
report of lower plasma F2-isoprostanes in high pFIT and 
ExFreq in a community setting. 
Plasma is endowed with antioxidant enzymes, macro- 
molecules, and small molecules, the sum of which is 
referred to as antioxidant capacity. Plasma antioxidant 
capacity can be modulated by diet, lifestyle, and disease 
state. FRAP did not differ across pFIT tertiles, but a 
trend for elevated levels (4.7%) was found in the high 
ExFreq tertile. Overall, FRAP levels differed by gender, 
age, and BMI, with elevated levels found in older males 
with higher BMI (see online Supporting Information). 
Plasma ORAC, however, did not differ across pFIT and 
ExFreq tertiles and was not related to any of the meas- 
ured confounders. 
The primary strength of this study was the measure- 
ment of a broad array of inflammatory and oxidative 
stress biomarkers in a heterogeneous group of 
community-based adults, with GLM analysis of rela- 
tionships to pFIT and ExFreq while controlling for 
important confounders. Indeed, six of the 10 measured 
biomarkers were significantly different across pFIT 
and/or ExFreq tertiles after adjusting for confounders. 
Our findings extend those reported in other population- 
based,  cross-sectional  studies,  but   contrast   with 
some randomized, exercise training studies that  indi- 
cate no independent influence on inflammation and 
oxidative stress. One explanation is that the change in 
aerobic fitness is often small, the duration of training 
seldom extends beyond  6  months,  and  the  number 
of subjects is relatively small in exercise intervention 
trials (Arsenault et al., 2009; Campbell et al., 2010; 
Christiansen et al., 2010; Church et al., 2010; Stewart 
et al., 2010; Thompson et al., 2010). In contrast, in 
large community, observational  studies,  the  difference 
in ExFreq, and physical fitness levels far exceeds 
changes that are attainable in the training studies. For 
example, in our subjects, ExFreq varied widely (from 
1 to 2:: 5 days per week) between low and high ter- 
tiles, and more than half of our subjects who reported 
regular physical activity had maintained  this  lifestyle 
five or more years (data not shown). 
 
 
Perspectives 
Physical inactivity increases the incidence of numerous 
chronic diseases (Booth et al., 2000),  many  of  which 
are associated with chronic low-grade inflammation and 
 
 
oxidative stress  (Morrow,  2005;  Basu,  2008;  Beavers 
et al., 2010). Conversely, lean and highly fit endurance 
athletes have low levels of these biomarkers in the rested 
state. In this epidemiologic study of community- 
dwelling adults, pFIT levels and/or leisure-time ExFreq 
were associated with decreased levels of six of 10 of 
these factors even after adjustment for the important 
confounders BMI, age, gender, and smoking status. Pre- 
vious studies have shown these relationships for many of 
the biomarkers studied, but this is the first study to estab- 
lish a similar linkage to GCSF. In conclusion, our data 
indicate that the combination of low BMI and high levels 
of pFIT and/or self-reported aerobic activity frequency 
have a strong relationship with low levels of inflamma- 
tion and oxidative stress. 
 
Key words: cytokines, granulocyte colony-stimulating 
factor, F2-isoprostanes, antioxidant capacity, leukocytes, 
body mass index, perceived physical fitness. 
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